Consolidated Condensed Statements Of Cash Flows - USD ($)
$ in Thousands |
6 Months Ended |
Jan. 31, 2016 |
Jan. 31, 2015 |
| Capital Expenditures Incurred but Not yet Paid |
$ 4,425
|
$ 4,016
|
| Non-cash capital expenditures under long-term financing |
0
|
7,037
|
| Cash flows from operating activities: |
|
|
| Net income (loss) |
57,201
|
51,376
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
79,241
|
73,345
|
| Cost of real estate sales |
9,444
|
12,620
|
| Stock-based compensation expense |
8,390
|
8,226
|
| Deferred income taxes, net |
35,937
|
24,321
|
| Change in Fair Value of Contingent Consideration |
0
|
(4,550)
|
| Gain (Loss) Related to Litigation Settlement |
0
|
(16,400)
|
| Park City litigation payment to Talisker |
0
|
(10,000)
|
| Other non-cash income, net |
(2,134)
|
(2,577)
|
| Increase (Decrease) in Restricted Cash |
(6,894)
|
(311)
|
| Changes in assets and liabilities: |
|
|
| Trade receivables, net |
27,696
|
28,742
|
| Inventories, net |
(5,263)
|
(5,358)
|
| Accounts payable and accrued liabilities |
111,778
|
129,655
|
| Other assets and liabilities, net |
(19,716)
|
(15,526)
|
| Net cash provided by operating activities |
309,468
|
274,185
|
| Cash flows from investing activities: |
|
|
| Capital expenditures |
(77,237)
|
(74,020)
|
| Acquisition of businesses |
(20,245)
|
(182,500)
|
| Other investing activities, net |
3,961
|
704
|
| Net cash used in investing activities |
(93,521)
|
(255,816)
|
| Proceeds from Issuance of Other Long-term Debt |
105,000
|
243,000
|
| Line of Credit Facility, Periodic Payment |
225,500
|
243,000
|
| Repayments of Term Loan |
(3,125)
|
0
|
| Repayments of Long-term Debt |
(257)
|
(536)
|
| Cash flows from financing activities: |
|
|
| Dividends paid |
(45,221)
|
(30,141)
|
| Payments for Repurchase of Common Stock |
(40,000)
|
0
|
| Other financing activities, net |
3,925
|
4,593
|
| Net cash used in financing activities |
(205,178)
|
(26,084)
|
| Effect of exchange rate changes on cash and cash equivalents |
(860)
|
(113)
|
| Net decrease in cash and cash equivalents |
9,909
|
(7,828)
|
| Cash and cash equivalents: |
|
|
| Beginning of period |
35,459
|
44,406
|
| End of period |
$ 45,368
|
$ 36,578
|